Jackie Doyle-Price: ...with respect to colour and design of the packaging when presented to the market place. Published research points to the similarity of packaging contributing adversely to selection errors in the pharmacy and other clinical settings. In addition, we are also mindful of the views expressed by patients whereby differences in appearance of medicines from different suppliers can be confusing....
Jim Cunningham: To ask the Secretary of State for Health and Social Care, how many pharmacies there have been in England in each year since 2010.
Bim Afolami: To ask the Secretary of State for Health, what steps the Government is taking to implement the recommendations of the independent review of community pharmacy clinical services commissioned by the NHS.
Bim Afolami: To ask the Secretary of State for Health, what steps his Department has taken to roll-out a minor ailments scheme through community pharmacies as recommended by the independent review of community pharmacy clinical services.
Bim Afolami: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the merits of community pharmacist supplementary and independent prescribing clinics in Scotland for England.
Bim Afolami: ...Social Care, what assessment he has made of the merits of proposals to permit community pharmacists to identify and manage uncomplicated cases of hypertension as part of the forthcoming community pharmacy funding negotiations.
Julie Cooper: ...Statement of the Parliamentary Under-Secretary of State for Health of 20 October 2016, Official Report, column 971, for what reason the Government has not encouraged the national roll-out of the pharmacy minor ailments scheme with clinical commissioning groups.
Kevin Barron: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support greater collaboration between GP surgeries and community pharmacies to ensure the optimal usage of medicines at primary care level.
Kevin Barron: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential contribution of community pharmacies to building long term value in the health and social care system at the (a) local and (b) primary care level.
Julie Cooper: To ask the Secretary of State for Digital, Culture, Media and Sport, for what reasons independent community pharmacies and other primary healthcare providers are designated as a public authority for the purpose of General Data Protection Regulation.
Julie Cooper: To ask the Secretary of State for Health and Social Care, what funds have been appropriated from the Pharmacy Integration Fund, in each year on (a) schemes to support pharmacists working in GP surgeries, (b) schemes to support community pharmacies to become better integrated with the NHS and (c) deferring the cost of (i) other parts of the NHS and (ii) wider Government expenditure.
Julie Cooper: To ask the Secretary of State for Health and Social Care, what assessment his Department has made on the financial effect of appointing a data protection officer on (a) independent community pharmacies and (b) other primary healthcare providers.
Julie Cooper: ...for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health of 20 December 2016, Official Report, how much of the £300 million pharmacy integration fund has been expended.
Julie Cooper: ...and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health of 20 December 2016, Official Report, what projects have been funded through the pharmacy integration fund to support improvements in (a) repeat prescriptions and (b) minor ailment services in England.
Kevin Barron: ..., pursuant to the Answer of 23 April 2018 to Question 136485, what recent assessment he has made of the level of uptake and adoption of technology for reducing inadvertent dispensing errors in (a) pharmacies and (b) acute settings.
Lord O'Shaughnessy: ...were sent to our target locations, GP practices, but there is also evidence that the toolkits were being used in the wider community setting with orders coming in from local councils, libraries and pharmacies. NHS England is at the early stage of planning a further Diabetes Prevention week in 2019. There were 6,694 completions of the Diabetes ‘Know Your Risk’ tool in Diabetes...
Steve Brine: ...to National Health Service patients using the FP10 prescription form. There are various other routes in which such medication can be supplied to a patient from the NHS including from community pharmacies via voucher schemes and a direct supply to patients from a Patient Group Direction. Smoking cessation drugs are classified under section British National Formulary (BNF) 4.10.2, Nicotine...
Julie Cooper: To ask the Secretary of State for Health and Social Care, what projects have been supported by the 2016-18 budget of the Pharmacy Integration Fund.
Lord O'Shaughnessy: ...listed the pack size covers three months. The difference in pack sizes means that different prices are not necessarily directly comparable. Reimbursement prices are the amounts paid to community pharmacies for dispensed products against an NHS prescription. Reimbursement price for oral contraceptives (Word Document, 28.63 KB)
Lord O'Shaughnessy: ...the Government to reimburse for special medicinal products (also known as ‘specials’) dispensed in primary care in different ways such as considering quotes of suppliers and not reimbursing pharmacies at all if for example they have been provided the medicine by a central service. The Government is considering how to implement its powers in the 2017 Act and any proposals to...